{"disease":{"id":"seroconversion","name":"seroconversion"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04756271","title":"Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":246,"lead_sponsor_name":"Zagazig University","has_results":false},{"nct_id":"NCT01924754","title":"Gardasil Immunogenicity With Needle-Free Injection","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT03449706","title":"Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection","phase":"","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"University Hospital, Ghent","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}